Cargando…
A comparison of immunotoxic effects of nanomedicinal products with regulatory immunotoxicity testing requirements
Nanomaterials (NMs) are attractive for biomedical and pharmaceutical applications because of their unique physicochemical and biological properties. A major application area of NMs is drug delivery. Many nanomedicinal products (NMPs) currently on the market or in clinical trials are most often based...
Autores principales: | Giannakou, Christina, Park, Margriet VDZ, de Jong, Wim H, van Loveren, Henk, Vandebriel, Rob J, Geertsma, Robert E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4922791/ https://www.ncbi.nlm.nih.gov/pubmed/27382281 http://dx.doi.org/10.2147/IJN.S102385 |
Ejemplares similares
-
Nonclinical regulatory immunotoxicity testing of nanomedicinal products: Proposed strategy and possible pitfalls
por: Giannakou, Christina, et al.
Publicado: (2020) -
Nanomedicinal products: a survey on specific toxicity and side effects
por: Brand, Walter, et al.
Publicado: (2017) -
Immunotoxicity Considerations for Next Generation Cancer Nanomedicines
por: Hannon, Gary, et al.
Publicado: (2019) -
Immunotoxicity of silver nanoparticles in an intravenous 28-day repeated-dose toxicity study in rats
por: Vandebriel, Rob J, et al.
Publicado: (2014) -
Consideration of pathways for immunotoxicity of per- and polyfluoroalkyl substances (PFAS)
por: Ehrlich, Veronika, et al.
Publicado: (2023)